ArticleScientific reports2025
Sirtuin 3 promotes osteogenic differentiation of bone marrow mesenchymal stem cells by regulating macrophage polarization under high glucose.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Under high glucose conditions, the bone repair process is impaired, in which macrophage polarization plays a critical role. This study aims to investigate the role of the Sirtuin 3/Forkhead box O3a (SIRT3/FoxO3a) pathway in regulating macrophage polarization under hyperglycemic conditions and its impact on the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). By establishing an in vitro high-glucose model in RAW264.7 macrophages, we found that high glucose suppressed the SIRT3/FoxO3a pathway, leading to increased reactive oxygen species (ROS) levels, reduced autophagy activity, and promoted polarization of macrophages toward the M1 phenotype. In contrast, SIRT3 overexpression reversed these effects, promoting macrophage polarization toward the M2 phenotype. When BMSCs were co-cultured with conditioned medium from macrophages, the medium derived from SIRT3-overexpressing macrophages significantly enhanced the proliferation, migration, and osteogenic differentiation capacity of BMSCs. The findings suggest that targeting the SIRT3/FoxO3a pathway may represent a promising novel strategy for improving bone healing in diabetic patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.